Project-001
项目-001
基本信息
- 批准号:10020376
- 负责人:
- 金额:$ 42.78万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-09-18 至 2024-07-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAlgorithmsB-LymphocytesBiological AssayCancer BurdenCancer EtiologyCaribbean regionCaringCessation of lifeChildClinicClinicalClinical TrialsCollaborationsCollectionCommunicationCountryDiagnosisDominican RepublicDoseEnsureFutureFuture GenerationsGeneral PopulationGoalsHIVHuman Papilloma Virus VaccinationHuman Papilloma Virus VaccineHuman Papilloma Virus-Related Malignant NeoplasmImmunotherapyIncidenceInfrastructureInterruptionLaboratoriesLatin AmericaLesionMalignant neoplasm of cervix uteriMinorityModelingMonitorNational Cancer InstitutePersonsPeruPopulationPreventionPrevention approachPrevention strategyPrimary Health CarePrimary PreventionProtocols documentationProviderQuality ControlRegimenResearch PersonnelResourcesSafetySamplingScheduleSiteStatistical Data InterpretationTimeTrainingTriageVaccinationVaccinesVisitVulnerable PopulationsWomanWorkcancer preventioncancer therapycervical cancer preventioncostdata managementdesigneffectiveness testingexperienceimmunogenicityimprovedlow and middle-income countrieslow income countrymortalitynew technologynovelnovel strategiespremalignantprogramsrecruitresponsescreeningstatisticssuccesstreatment strategy
项目摘要
Worldwide, cervical cancer is the fourth leading cause of cancer incidence and mortality; 80% of cervical
cancers arise and 87% of cervical cancer deaths occur in low and lower-middle income countries. In Peru,
cervical cancer is diagnosed at a rate of 17 per 100,000 women per year, and in the DR at 23 per 100,000
annually among women in the general population. The burden of cervical cancer is substantially increased
among women living with HIV (WLWH), although the exact rates are not well described. Although HPV
vaccines are safe and effective as primary prevention, they have limited availability in low resource settings
and the optimal regimen of vaccine doses for HIV-infected persons in such settings has not been defined.
Furthermore, delivery of cervical cancer prevention and treatment of precursors for WLWH in low- and middle-income
countries is impeded by approaches that are often costly, require multiple visits and extensive provider
training. Moreover, many of these are not suitable for delivery within an HIV primary care model.
The Cervical Cancer Prevention Partnership (C2P2) Center involves two clinical trial sites, in Peru and the
Dominican Republic, and three cores (Administrative and Coordinating Core, Statistics and Data Management
Core and Central Laboratory Core) in Seattle. Investigators in the C2P2 Center will jointly design, conduct and
analyze three clinical trials with the goal of moving toward elimination of cervical cancer among highly
vulnerable populations with HIV in low resource settings in Latin America and the Caribbean (LAC). We seek
to improve the quality and efficiency of prevention strategies using new approaches that will augment the
existing infrastructure at local HIV clinics in Peru and the Dominican Republic (DR). The aims of the
proposed Clinical Trials Center span the continuum of cervical cancer prevention from vaccination
through treatment. The trials we propose will address these technical issues and provide a more direct pipeline
for prevention. In this C2P2 Center, our overarching aims are:
Specific Aim 1: To test the effectiveness of novel approaches to cervical cancer prevention in high-burden
HIV-infected populations in Peru and the DR by performing three clinical trials. One will assess
the ability of HPV vaccination regimens to elicit long-lasting B cell responses, and two will assess novel
screening, triage, and treatment approaches that will improve the quality and reach of prevention in
low-resource settings throughout the LAC region.
Specific Aim 2: To build a robust multidirectional collaboration between study investigators at all sites
that serves the needs of providers who care for women living with HIV. The Center will engage with
leaders in the region to enhance the sustainability of efforts that target future elimination of cervical
cancer through multiple high-impact prevention and treatment strategies.
在世界范围内,宫颈癌是癌症发病率和死亡率的第四大原因;80%的宫颈癌
癌症发生,87%的宫颈癌死亡发生在低收入和中低收入国家。在秘鲁,
宫颈癌的诊断率为每年每10万名妇女中有17人被确诊,而在DR中,每年每10万人中有23人被诊断为宫颈癌
每年在一般人口中的妇女中。宫颈癌的负担大幅增加
在感染艾滋病毒(WLWH)的妇女中,尽管没有很好地描述确切的比率。虽然人乳头瘤病毒
疫苗作为一级预防是安全有效的,它们在资源匮乏的情况下可获得的机会有限
在这种情况下,艾滋病毒感染者的最佳疫苗剂量还没有确定。
此外,在中低收入人群中提供宫颈癌预防和治疗WLWH先兆
国家/地区往往受到成本高昂、需要多次访问和广泛提供服务的方法的阻碍
训练。此外,其中许多不适合在艾滋病毒初级保健模式下提供。
宫颈癌预防伙伴关系(C2P2)中心涉及两个临床试验地点,分别位于秘鲁和
多米尼加共和国和三个核心(行政和协调核心、统计和数据管理
核心和中心实验室核心)在西雅图。C2P2中心的调查人员将联合设计、进行和
分析三项旨在消除高危人群宫颈癌的临床试验
拉丁美洲和加勒比(LAC)资源匮乏地区的艾滋病毒感染者弱势群体。我们在寻找
使用新的方法提高预防战略的质量和效率,以增强
秘鲁和多米尼加共和国(DR)当地艾滋病毒诊所的现有基础设施。该计划的目标是
拟议的临床试验中心跨越了接种疫苗预防宫颈癌的连续过程
通过治疗。我们提议的试验将解决这些技术问题,并提供更直接的渠道
用于预防。在这个C2P2中心,我们的首要目标是:
的具体目标1:测试新方法在高负担人群预防宫颈癌的有效性
秘鲁和DR的艾滋病毒感染人群进行了三项临床试验。其中一人将评估
HPV疫苗接种方案能否引发持久的B细胞反应,其中两种将评估新的
筛查、分类和治疗方法将提高预防的质量和覆盖面
整个LAC区域的低资源设置。
的具体目标2:在所有地点的研究人员之间建立强有力的多方向协作
这满足了护理艾滋病毒携带者妇女的提供者的需求。该中心将与
该地区领导人加强旨在未来消除宫颈癌的努力的可持续性
通过多种高影响力的癌症预防和治疗策略。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Robinson Cabello其他文献
Robinson Cabello的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Robinson Cabello', 18)}}的其他基金
Colaboracion Evita: HPV-Related Cancer Prevention Partnership Center
Colaboracion Evita:HPV 相关癌症预防合作中心
- 批准号:
10689708 - 财政年份:2019
- 资助金额:
$ 42.78万 - 项目类别:
Colaboracion Evita: HPV-Related Cancer Prevention Partnership Center
Colaboracion Evita:HPV 相关癌症预防合作中心
- 批准号:
10224781 - 财政年份:2019
- 资助金额:
$ 42.78万 - 项目类别:
Colaboracion Evita: HPV-Related Cancer Prevention Partnership Center
Colaboracion Evita:HPV 相关癌症预防合作中心
- 批准号:
10020371 - 财政年份:2019
- 资助金额:
$ 42.78万 - 项目类别:
Colaboracion Evita: HPV-Related Cancer Prevention Partnership Center
Colaboracion Evita:HPV 相关癌症预防合作中心
- 批准号:
10470111 - 财政年份:2019
- 资助金额:
$ 42.78万 - 项目类别:
相似海外基金
DMS-EPSRC: Asymptotic Analysis of Online Training Algorithms in Machine Learning: Recurrent, Graphical, and Deep Neural Networks
DMS-EPSRC:机器学习中在线训练算法的渐近分析:循环、图形和深度神经网络
- 批准号:
EP/Y029089/1 - 财政年份:2024
- 资助金额:
$ 42.78万 - 项目类别:
Research Grant
CAREER: Blessing of Nonconvexity in Machine Learning - Landscape Analysis and Efficient Algorithms
职业:机器学习中非凸性的祝福 - 景观分析和高效算法
- 批准号:
2337776 - 财政年份:2024
- 资助金额:
$ 42.78万 - 项目类别:
Continuing Grant
CAREER: From Dynamic Algorithms to Fast Optimization and Back
职业:从动态算法到快速优化并返回
- 批准号:
2338816 - 财政年份:2024
- 资助金额:
$ 42.78万 - 项目类别:
Continuing Grant
CAREER: Structured Minimax Optimization: Theory, Algorithms, and Applications in Robust Learning
职业:结构化极小极大优化:稳健学习中的理论、算法和应用
- 批准号:
2338846 - 财政年份:2024
- 资助金额:
$ 42.78万 - 项目类别:
Continuing Grant
CRII: SaTC: Reliable Hardware Architectures Against Side-Channel Attacks for Post-Quantum Cryptographic Algorithms
CRII:SaTC:针对后量子密码算法的侧通道攻击的可靠硬件架构
- 批准号:
2348261 - 财政年份:2024
- 资助金额:
$ 42.78万 - 项目类别:
Standard Grant
CRII: AF: The Impact of Knowledge on the Performance of Distributed Algorithms
CRII:AF:知识对分布式算法性能的影响
- 批准号:
2348346 - 财政年份:2024
- 资助金额:
$ 42.78万 - 项目类别:
Standard Grant
CRII: CSR: From Bloom Filters to Noise Reduction Streaming Algorithms
CRII:CSR:从布隆过滤器到降噪流算法
- 批准号:
2348457 - 财政年份:2024
- 资助金额:
$ 42.78万 - 项目类别:
Standard Grant
EAGER: Search-Accelerated Markov Chain Monte Carlo Algorithms for Bayesian Neural Networks and Trillion-Dimensional Problems
EAGER:贝叶斯神经网络和万亿维问题的搜索加速马尔可夫链蒙特卡罗算法
- 批准号:
2404989 - 财政年份:2024
- 资助金额:
$ 42.78万 - 项目类别:
Standard Grant
CAREER: Efficient Algorithms for Modern Computer Architecture
职业:现代计算机架构的高效算法
- 批准号:
2339310 - 财政年份:2024
- 资助金额:
$ 42.78万 - 项目类别:
Continuing Grant
CAREER: Improving Real-world Performance of AI Biosignal Algorithms
职业:提高人工智能生物信号算法的实际性能
- 批准号:
2339669 - 财政年份:2024
- 资助金额:
$ 42.78万 - 项目类别:
Continuing Grant